US Stock MarketDetailed Quotes

ALBT Avalon GloboCare

Watchlist
  • 7.250
  • -0.150-2.03%
Close Feb 28 16:00 ET
  • 7.250
  • 0.0000.00%
Post 20:01 ET
7.93MMarket Cap-0.36P/E (TTM)

About Avalon GloboCare Company

Avalon GloboCare Corp. is a clinical-stage biotechnology company, which engages in the development of immune effector cell therapy and laboratory services. It operates through the Real Property Operating and Medical Related Consulting Services segments. The Real Property Operating segment includes property management fees, property insurance, real estate taxes, depreciation, repairs and maintenance fees, utilities and other expenses related to rental properties. The Medical Related Consulting segment relates to labor and related benefits, travel expenses, and related to consulting services. The company was founded on July 28, 2014 and is headquartered in Freehold, NJ.

Company Profile

SymbolALBT
Company NameAvalon GloboCare
Listing DateNov 5, 2018
Founded2014
CEODr. David Jin, M.D.,PhD
MarketNASDAQ
Employees5
Fiscal Year Ends12-31
Address4400 Route 9 South,Suite 3100
CityFreehold
ProvinceNew Jersey
CountryUnited States of America
Zip Code07728
Phone1-732-780-4400

Company Executives

  • Name
  • Position
  • Salary
  • Dr. David Jin, M.D.,PhD
  • President, Chief Executive Officer and Director
  • 330.00K
  • Luisa Ingargiola
  • Chief Financial Officer and Principal Accounting Officer
  • 350.00K
  • Meng Li
  • Chief Operating Officer and Secretary
  • 280.24K
  • Wenzhao Lu
  • Chairman of the Board
  • 100.00K
  • Wilbert J. Tauzin, II
  • Director
  • 38.05K
  • Steven A. Sanders
  • Independent Director
  • 103.67K
  • Dr. Tevi Troy, B.S.,M.A.,PhD
  • Independent Director
  • 93.67K
  • Lourdes Felix
  • Independent Director
  • 91.76K
  • William B. Stilley, III,M.B.A.
  • Independent Director
  • 103.67K

Trending Stocks

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
Unlock Now
Reassessing Chinese Assets
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.
Discussing
Widespread uptick! What's ahead for Chinese stocks in 2025?
Recently, institutions such as Goldman Sachs, Morgan Stanley, and Appaloosa LP have spoken positively about Chinese assets. Chinese stocks l Show More